Related references
Note: Only part of the references are listed.Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis
Zhiguang Huo et al.
NEUROBIOLOGY OF AGING (2020)
Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome
Matthias Arnold et al.
NATURE COMMUNICATIONS (2020)
Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders
Baruh Polis et al.
NEURAL REGENERATION RESEARCH (2020)
Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging
Marta Gonzalez-Freire et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease
Pratishtha Chatterjee et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
Kwangsik Nho et al.
ALZHEIMERS & DEMENTIA (2019)
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome
Siamak MahmoudianDehkordi et al.
ALZHEIMERS & DEMENTIA (2019)
Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms
Gloria Castellano-Gonzalez et al.
NEUROTOXICITY RESEARCH (2019)
High-Throughput Plasma Lipidomics: Detailed Mapping of the Associations with Cardiometabolic Risk Factors
Kevin Huynh et al.
CELL CHEMICAL BIOLOGY (2019)
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
Kwangsik Nho et al.
JAMA NETWORK OPEN (2019)
Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts
Juho Tynkkynen et al.
ALZHEIMERS & DEMENTIA (2018)
Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging
Fabian Dorninger et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection
Tatiana N. Tarasenko et al.
MOLECULAR GENETICS AND METABOLISM (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Kynurenine pathway in depression: A systematic review and meta-analysis
Kamiyu Ogyu et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
Gislaine Z. Reus et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Vijay R. Varma et al.
PLOS MEDICINE (2018)
Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study
Jun Liu et al.
METABOLOMICS (2017)
Kynurenine pathway metabolites and suicidality
Elena Y. Bryleva et al.
NEUROPHARMACOLOGY (2017)
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman et al.
SCHIZOPHRENIA BULLETIN (2017)
Branched-chain amino acids and Alzheimer's disease: a Mendelian randomization analysis
Susanna C. Larsson et al.
SCIENTIFIC REPORTS (2017)
Metabolic network failures in Alzheimer's disease: A biochemical road map
Jon B. Toledo et al.
ALZHEIMERS & DEMENTIA (2017)
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod et al.
ALZHEIMERS & DEMENTIA (2017)
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
Michael W. Weiner et al.
ALZHEIMERS & DEMENTIA (2017)
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis
Petroula Proitsi et al.
ALZHEIMERS & DEMENTIA (2017)
Blood metabolite markers of cognitive performance and brain function in aging
Brittany N. Simpson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Alzheimer's Disease Risk Genes and Lipid Regulators
Farida El Gaamouch et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
L. Brundin et al.
TRANSLATIONAL PSYCHIATRY (2016)
Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia
Adriana Cristofano et al.
PLOS ONE (2016)
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans
Andrew J. Saykin et al.
ALZHEIMERS & DEMENTIA (2015)
Protective Variant for Hippocampal Atrophy Identified by Whole Exome Sequencing
Kwangsik Nho et al.
ANNALS OF NEUROLOGY (2015)
Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry
Raul Gonzalez-Dominguez et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer's disease
Raul Gonzalez-Dominguez et al.
TALANTA (2015)
Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease
P. Proitsi et al.
TRANSLATIONAL PSYCHIATRY (2015)
JB Special Review-Recent Progress in Lipid Mediators Lysophosphatidic acid as a lipid mediator with multiple biological actions
Shizu Aikawa et al.
JOURNAL OF BIOCHEMISTRY (2015)
Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease
R. Gonzalez-Dominguez et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry
R. Gonzalez-Dominguez et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease
Raul Gonzalez-Dominguez et al.
JOURNAL OF PROTEOMICS (2014)
Plasma phospholipids identify antecedent memory impairment in older adults
Mark Mapstone et al.
NATURE MEDICINE (2014)
Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease
Luke Whiley et al.
NEUROBIOLOGY OF AGING (2014)
Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases
Jazmin Reyes Ocampo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
The role of phosphatidylcholine and choline metabolites to cell proliferation and survival
Neale D. Ridgway
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Acylcarnitines Reflecting or Inflicting Insulin Resistance?
Marieke G. Schooneman et al.
DIABETES (2013)
Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach
Anna Floegel et al.
DIABETES (2013)
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
Shannon L. Risacher et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Paul K. Crane et al.
BRAIN IMAGING AND BEHAVIOR (2012)
A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment
Laura E. Gibbons et al.
BRAIN IMAGING AND BEHAVIOR (2012)
Carnitine and Acylcarnitines
Stephanie E. Reuter et al.
CLINICAL PHARMACOKINETICS (2012)
Novel biomarkers for pre-diabetes identified by metabolomics
Rui Wang-Sattler et al.
MOLECULAR SYSTEMS BIOLOGY (2012)
Characterization of D-3-hydroxybutyrylcarnitine (ketocarnitine): an identified ketosis-induced metabolite
Maarten R. Soeters et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil
Mathieu Gaudin et al.
BIOANALYSIS (2012)
Short-Term Effects of Dietary Fatty Acids on Muscle Lipid Composition and Serum Acylcarnitine Profile in Human Subjects
C. Lawrence Kien et al.
OBESITY (2011)
Metabolism and atherogenic disease association of lysophosphatidylcholine
Gerd Schmitz et al.
ATHEROSCLEROSIS (2010)
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis
Norman J. Haughey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Phospholipase A2 and arachidonic acid in Alzheimer's disease
Rene O. Sanchez-Mejia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Lipid Alterations in Lipid Rafts from Alzheimer's Disease Human Brain Cortex
Virginia Martin et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
J. K. Yao et al.
MOLECULAR PSYCHIATRY (2010)
Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity
Stephanie J. Mihalik et al.
OBESITY (2010)
Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women
Oliver Fiehn et al.
PLOS ONE (2010)
A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance
Christopher B. Newgard et al.
CELL METABOLISM (2009)
Proteolytic mechanisms in amyloid-β metabolism:: therapeutic implications for Alzheimer's disease
ERLC Vardy et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment - Results from the Cardiovascular Health Study
CG Lyketsos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
